Vigil Neuroscience Statistics Share Statistics Vigil Neuroscience has 47.69M
shares outstanding. The number of shares has increased by 17.72%
in one year.
Shares Outstanding 47.69M Shares Change (YoY) 17.72% Shares Change (QoQ) 0% Owned by Institutions (%) 40.63% Shares Floating 31.28M Failed to Deliver (FTD) Shares 5 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 447.39K, so 0.96% of the outstanding
shares have been sold short.
Short Interest 447.39K Short % of Shares Out 0.96% Short % of Float 1.26% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.82 and the forward
PE ratio is -5.19.
Vigil Neuroscience's PEG ratio is
0.29.
PE Ratio -0.82 Forward PE -5.19 PS Ratio 0 Forward PS 25.3 PB Ratio 0.97 P/FCF Ratio -1.35 PEG Ratio 0.29
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vigil Neuroscience.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.95,
with a Debt / Equity ratio of 0.18.
Current Ratio 2.95 Quick Ratio 2.95 Debt / Equity 0.18 Debt / EBITDA -0.15 Debt / FCF -0.25 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.22M Employee Count 69 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 162.21% in the
last 52 weeks. The beta is 3.34, so Vigil Neuroscience's
price volatility has been higher than the market average.
Beta 3.34 52-Week Price Change 162.21% 50-Day Moving Average 7.97 200-Day Moving Average 3.82 Relative Strength Index (RSI) 78.76 Average Volume (20 Days) 1,650,224
Income Statement
Revenue n/a Gross Profit -453K Operating Income -89.68M Net Income -84.26M EBITDA -83.8M EBIT -84.26M Earnings Per Share (EPS) -2.07
Full Income Statement Balance Sheet The company has 39.02M in cash and 12.95M in
debt, giving a net cash position of 26.07M.
Cash & Cash Equivalents 39.02M Total Debt 12.95M Net Cash 26.07M Retained Earnings -307.03M Total Assets 86.7M Working Capital 36.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -51.22M
and capital expenditures -5K, giving a free cash flow of -51.23M.
Operating Cash Flow -51.22M Capital Expenditures -5K Free Cash Flow -51.23M FCF Per Share -1.26
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
